Araujo David, Bruna https://orcid.org/0000-0001-8486-329X
Andreata, Francesco https://orcid.org/0000-0002-5710-3671
Blériot, Camille https://orcid.org/0000-0002-4298-2888
Ginhoux, Florent https://orcid.org/0000-0002-2857-7755
Kubes, Paul https://orcid.org/0000-0002-2835-4244
Iannacone, Matteo https://orcid.org/0000-0002-9370-2671
Article History
Accepted: 24 February 2026
First Online: 8 April 2026
Competing interests
: M.I. participates in advisory boards/consultantship or receives funding from Gilead Sciences, BioNTech, Curie.Bio, AstraZeneca and Pilatus Biosciences. The other authors declare no competing interests.